Pulse therapy. Therapeutic efficacy in the treatment of pyoderma gangrenosum.
D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000276:immunology; D007263:Infusions, Parenteral; D008214:Lymphocytes / Q000187:drug effects; D008264:Macrophages / Q000187:drug effects; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D008776:Methylprednisolone Hemisuccinate / Q000008:administration & dosage*; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects; D011711:Pyoderma / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D012883:Skin Ulcer / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology
D007136:Immunoglobulins; D008776:Methylprednisolone Hemisuccinate; D008775:Methylprednisolone